- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
Patent holdings for IPC class A61K 31/7048
Total number of patents in this class: 4736
10-year publication summary
|
354
|
361
|
404
|
441
|
500
|
471
|
412
|
358
|
333
|
106
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Société des Produits Nestlé S.A. | 9987 |
74 |
| Boehringer Ingelheim International GmbH | 4510 |
66 |
| The Board of Trustees of the University of Illinois | 2742 |
39 |
| Boehringer Ingelheim Vetmedica GmbH | 1270 |
34 |
| Suntory Holdings Limited | 2098 |
30 |
| The Regents of the University of California | 20556 |
28 |
| Insmed Incorporated | 265 |
26 |
| Massachusetts Institute of Technology | 10201 |
25 |
| AMOREPACIFIC Corporation | 2886 |
25 |
| Korea Research Institute of Bioscience and Biotechnology | 1062 |
24 |
| Amazentis SA | 196 |
22 |
| Phoenix Biotechnology, Inc. | 45 |
21 |
| RedHill Biopharma Ltd. | 98 |
21 |
| Zoetis Services LLC | 1544 |
21 |
| Evonik Operations GmbH | 4248 |
20 |
| Novartis AG | 10345 |
19 |
| Wisconsin Alumni Research Foundation | 3919 |
18 |
| The Brigham and Women's Hospital, Inc. | 2264 |
18 |
| Boehringer Ingelheim Animal Health USA Inc. | 419 |
18 |
| Galderma Holding S.A. | 694 |
18 |
| Other owners | 4169 |